werner@aecom.UUCP (Craig Werner) (10/01/85)
From: AMN 9/13/85 p. 36
"Diabetics vision problem's aided."
Suldinac, a non-steroidal anti-inflammatory drug (Aspirin,
Tylenol, and Motrin are also NSAIDs) appears to prevent blood-vessel
alterations associated with vision loss in diabetic patients, according to
a report in Sept. Archives of Opthamology.
J.G. Cunha-Vaz, MD/PhD, et al, of U.Illinois compared Suldinac
treatment with placebo in a group of 24 Insulin-dependent diabetic
patients and found that treated patients "had a significant beneficial
effect on the breakdown of the blood-retinal barrier." They say that long
term studies are now in order "to determine if the progression and
development of diabetic retinopathy and final vision loss can be
prevented."
--
Craig Werner
!philabs!aecom!werner
"Why is it that half the calories is twice the price?"